In 2013, Tonjes et al. observed overexpression of BCAT1, an important enzyme of BCAAs metabolism, in gliomas [12], and its expression in glioblastoma tumors was specific to those carrying IDH1 and IDH2. This evidence concerns the gene IDH1 and central nervous system cancer.